Basket cover image
11 handpicked stocks

Quantum Leap Investing

Dive into a collection of stocks at the forefront of quantum computing technology. These companies were carefully selected by our professional analysts for their potential to transform industries and create exponential growth opportunities in this revolutionary field.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+1

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at mai 12

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

IONQ

IonQ Inc

IONQ

Current price

$36.80

NVDA

NVIDIA Corporation

NVDA

Current price

$175.64

MSFT

Microsoft Corporation

MSFT

Current price

$509.77

About This Group of Stocks

1

Our Expert Thinking

Quantum computing represents a fundamental shift in computational power that could solve problems thousands of times faster than today's technology. These stocks provide exposure to companies leading this paradigm shift across hardware, software, and enabling technologies with long-term transformative potential.

2

What You Need to Know

This collection balances pure-play quantum computing firms with established tech giants that have dedicated quantum divisions. The quantum computing market is still in its early stages, making these investments suited for those with a longer time horizon who can tolerate some volatility.

3

Why These Stocks

These companies were selected for their leadership positions in quantum development, strategic investments in the technology, and potential competitive advantages. Our analysts identified both specialized quantum innovators and larger corporations positioned to benefit from breakthroughs in this revolutionary field.

Group Performance Snapshot

9 of 11

Stocks Rated Buy by Analysts

9 of 11 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🔮

The Future Is Quantum

These companies are developing technology that could solve 10,000-year problems in minutes. Getting in early could mean capturing extraordinary growth as quantum computing transforms entire industries.

🧩

Still Under The Radar

Quantum computing hasn't yet hit mainstream investor attention. This creates an opportunity to invest before the technology reaches its commercial tipping point and widespread adoption begins.

🚀

Multiple Growth Catalysts

From AI and drug discovery to cybersecurity and financial modeling, quantum breakthroughs could trigger growth across multiple sectors simultaneously. These stocks give you exposure to this potential multi-industry revolution.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Beyond The App Store: Europe's New Rules

Beyond The App Store: Europe's New Rules

Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.

View stocks
The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.